WILMINGTON, Del., May 14, 2024--Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress
The biopharmaceutical company is offering to buy up to $1.672 billion worth of its stock via the auction. It is also buying up to $372 million from a board member and other entities.